eaa777cd_CER_Inventory___CER_Inventory__Category
[Agency] NIH [Project Title] COENZYME Q10 IN STATIN MYOPATHY [Institution] HARTFORD HOSPITAL [Amount] $457,436 [Summary] Statins markedly reduce the incidence of cardiac events. These drugs are generally well-tolerated but can produce muscle side effects such as muscle cramps and weakness, which can ultimately require withdrawal of medications for statin-intolerant subjects. The current study investigates the utility of Coenzyme Q10 supplementation in patients with statin-associated muscle side effects to determine if Coenzyme Q10 supplementation is a novel therapeutic approach to improving statin tolerance. [Completion/ Closing Date] 10/01/2010 [Link] link [Category] 
Medical treatments, items and services
CER Inventory | CER Inventory
Category